Who Owns Bolt Biotherapeutics Stock?
NASDAQ: BOLTHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 27.92%
- Held by insiders
- 3.46%
- Institutional holders
- 25
- Institutions 27.9%
- Insiders 3.5%
- Public and other 68.6%
Who owns Bolt Biotherapeutics stock?
Institutional investors own about 27.9% of Bolt Biotherapeutics's shares, spread across 25 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 3.46% of BOLT.
The largest institutional holders are Sofinnova Investments, Inc. (7.15%), Renaissance Technologies, LLC (5.12%) and Vivo Capital, LLC (3.76%). Together, the top 10 institutions control 28.5% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their BOLT positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BOLT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Sofinnova Investments, Inc. | 137.72K | 7.15% | 0.0% |
| Renaissance Technologies, LLC | 98.63K | 5.12% | +27.7% |
| Vivo Capital, LLC | 72.41K | 3.76% | 0.0% |
| Citadel Advisors Llc | 56.90K | 2.95% | +462.9% |
| T3 Companies, LLC | 38.00K | 1.97% | 0.0% |
| Board Of Trustees Of The Leland Stanford Junior University | 35.98K | 1.87% | 0.0% |
| Pfizer Inc | 31.30K | 1.63% | 0.0% |
| Lynx1 Capital Management Lp | 30.80K | 1.60% | 0.0% |
| Nano Cap New Millennium Growth Fund L P | 27.50K | 1.43% | 0.0% |
| Geode Capital Management, LLC | 19.12K | 0.99% | -33.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BOLT
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 7.51K | 0.39% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 7.06K | 0.37% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 5.35K | 0.28% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.70K | 0.09% |
| Master Investment Portfolio-Diversified Equity Alpha Master Portfolio | 89 | 0.00% |
| Guggenheim Active Allocation Fund | 6 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Bolt Biotherapeutics?
Sofinnova Investments, Inc. is the largest institutional shareholder of BOLT, owning 7.15% of shares outstanding (137.72K shares) as of its latest 13F filing.
What percentage of Bolt Biotherapeutics is owned by institutions?
Institutions own about 27.9% of BOLT shares and 28.9% of the public float.
How much of Bolt Biotherapeutics do insiders own?
Insiders, such as officers and directors, own about 3.46% of BOLT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.